Independent.ie6h
Novo Nordisk shares plunge after obesity drug trial
Novo Nordisk’s share price plunged the most since December after another disappointment for the drugmaker’s next-generation ...
LifeMD, Inc. (LFMD) Q4 2024 Earnings Call Transcript
Q4 2024 Results Conference Call March 10, 2025 4:30 PM ETCompany ParticipantsJustin Schreiber - Chairman and Chief ...
Novo’s New Obesity Drug Disappoints Again, This Time in Diabetes
Novo Nordisk A/S shares plunged the most since December after another disappointment for the drugmaker’s next-generation shot ...
Novo Nordisk shares slide 6% after weight loss drug trial disappoints
Novo Nordisk shares declined on Monday after the company reported that its next-generation weight-loss drug, CagriSema, ...
SWI swissinfo.ch20h
Novo Falls After New-Generation Shot Struggles in Diabetes Trial
Novo Nordisk A/S shares fell the most since December after the drugmaker’s next-generation shot CagriSema fell short of some ...